COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

Related Keywords

United States ,American ,Emily Egbert ,Amanda Debes ,Elizabeth Colantuoni ,Diana Zhong ,Aaron Milstone ,Shaoming Xiao ,Emily Henderson ,Johns Hopkins Children Center ,Johns Hopkins Health System ,Infectious Diseases National Institutes Of Health ,National Institute Of Allergy ,Johns Hopkins University School Of Medicine ,Journal Of The American Medical Association ,Johns Hopkins Medicine ,American Medical ,Johns Hopkins University School ,Johns Hopkins Children ,Hopkins Medicine ,Patrizio Caturegli ,National Institute ,National Institutes ,Johns Hopkins Health ,Antibodies ,Ntibody ,Health Care ,Immune System ,Immunity ,Infectious Diseases ,Medicine ,Protein ,Research ,Na ,Cars ,Ars Cov 2 ,Vaccine ,Virus ,